Sign up


Match Document Document Title
US20110076214 Reversible Room-Temperature Ionic Liquids  
One aspect of the present invention relates to salts that are room-temperature ionic liquids (RTILs), methods of making them, and methods of using them in connection with temporary or permanent gas...
US20140343260 PET/SPECT AGENTS FOR APPLICATIONS IN BIOMEDICAL IMAGING  
Tracers that can be used for PET or SPECT imaging of the distribution of Pgp are disclosed. The tracers are metalloprobes that can comprise a radioactive metal ion such as 67Ga or 68Ga. Methods of...
US20110065957 SYNTHESIS OF BIURETS AND ISOCYANATES WITH ALKOXYSILANE FUNCTIONS, FORMULATIONS CONTAINING SAME AND USE THEREOF  
The invention relates to a composition and a method of preparing one such composition and an isocyanatoalkoxysilane; the polyisocyanate composition contains at least two different oligomeric...
US20140235872 NOVEL LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY  
The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with...
US20130178541 NOVEL LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY  
The instant invention provides for novel catiomc lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with...
US20130090372 Novel Low Molecular Weight Cationic Lipids for Oligonucleotide Delivery  
The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with...
US20140377345 CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG  
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time...
US20120269891 CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG  
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time...
US20140228580 METHOD FOR PURIFYING A CRUDE PNPNH COMPOUND  
The present invention relates to a method for purifying a crude PNPNH compound by metalation and re-protonation.
US20140314746 METHODS FOR TREATING OR PREVENTING FIBROSIS IN SUBJECTS AFFLICTED WITH SCLERODERMA  
The invention includes novel methods of treating or preventing fibrosis in a subject afflicted with scleroderma, comprising administering to the subject a therapeutically effective amount of an...
US20110301383 Beta-Diketiminate Ligand Sources and Metal-Containing Compounds Thereof, and Systems and Methods Including Same  
The present invention provides metal-containing compounds that include at least one β-diketiminate ligand, and methods of making and using the same. In certain embodiments, the metal-containing ...
US20120232171 Alkoxylated Cyclic Diamines And Use Thereof As Emulsion Breakers  
The invention relates to the use of alkoxylated cyclic diamines, the reactive groups of which are alkoxylated by means of at least one C2 to C4 alkylene oxide, and the average degree of...
US20110207909 Catalytic System of Nitrate Anions for CO2/ Epoxide Copolymerization  
This invention relates to a Salen type ligand including three or more quaternary ammonium salts of nitrate anions, to a trivalent metal complex compound prepared from this ligand and a method of...
US20130157845 SORBENTS FOR REMOVING MERCURY FROM EMISSIONS PRODUCED DURING FUEL COMBUSION  
Activated carbon is rendered more thermally stable by exposure to a non-halogenated additive, and optionally to a halogen and/or a halogen-containing compound. Such treated carbon is suitable for...
US20130096348 CHIRAL DIENE LIGANDS, A FABRICATION METHOD THEREOF AND APPLICATIONS THEREOF  
The present invention proposes a chiral diene ligand, a fabrication method thereof and applications thereof. The chiral diene ligand is a bicyclo[2.2.1] diene ligand having structural specificity...
US20110015201 HEDGEHOG PATHWAY ANTAGONISTS AND METHODS OF USE  
The present disclosure provides for compounds, pharmaceutical preparations, kits and methods for the inhibition of the Hh pathway and the alleviation of cancer and developmental disorders...
US20120022070 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use  
Novel classes of molecular chaperone Heat shock protein 90 (Hsp90) inhibitors are disclosed. These compounds are useful in treating and preventing cancer and other Hsp90-related diseases and...
US20120088162 Safe Battery Solvents  
An ion transporting solvent for use with batteries can be improved by simultaneously shortening a phosphazene compound's pendent groups, eliminating most or all of the distal ion carriers, and...
US20140329916 MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING ADIPATE, 6-AMINOCAPROATE, HEXAMETHYLENEDIAMINE OR CAPROLACTAM RELATED THERETO  
Provided herein is a non-naturally occurring microbial organism having a methanol metabolic pathway that can enhance the availability of reducing equivalents in the presence of methanol. Such...
US20120130132 METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER  
According to the present invention, a method for separating a primary amine being an N,N-dialkylbisaminoalkylether, from mixtures comprising said primary amine and at least one of a secondary amine...
US20110110984 Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds  
The present invention relates to pharmaceutical solid dosage forms for oral administration comprising a tri-substituted glycerol compound or a pharmaceutically acceptable salt thereof. The...
US20120203102 AZULENE AND AZAAZULENE SYSTEMS FOR IMAGING, MONITORING AND THERAPY  
This invention is directed to non-benzenoid aromatic compounds. Other aspects include methods of using non-benzenoid aromatic compounds for imaging and phototherapeutic uses thereof. Non-benzenoid...
US20140314779 CELL CULTURE COMPOSITIONS WITH ANTIOXIDANTS AND METHODS FOR POLYPEPTIDE PRODUCTION  
Cell culture media comprising antioxidants are provided herein as are methods of using the media for cell culturing and polypeptide production from cells. Compositions comprising polypeptides, such...
US20140286927 METHOD FOR THE TREATMENT OF ULCERATIVE COLITIS IN PATIENTS REFRACTORY TO STEROID THERAPY USING LEACHED LIGAND FIBRIN STABILIZING COMPOSITION  
A engineered composition and method of delivery of said composition providing effective therapy for the treatment of ulcerative colitis, and Crohn's disease.
US20110159597 ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASURING REAGENT, ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASURING METHOD, AND DETERMINATION METHOD FOR DETERMINING PRESENCE OR ABSENCE OF BLOOD COAGULATION INHIBITOR  
An activated partial thromboplastin time measuring reagent, comprising a heparin neutralizer is disclosed. An activated partial thromboplastin time measuring method, and a determination method for...
US20110041732 PROCESS FOR MANUFACTURING ASPHALT  
A process for manufacturing asphalt is disclosed. The process comprises the steps of: (i) heating bitumen; (ii) heating aggregate; and (iii) mixing the hot bitumen with the hot aggregate in a...
US20140155490 THERAPEUTIC COMPOUNDS  
The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for...
US20120149693 THERAPEUTIC COMPOUNDS  
The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for...
US20100305212 THERAPEUTIC COMPOUNDS  
The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for...
US20140275270 Isolated Stereoisomeric Forms Of (S)2-N(3-O-(Propan 2-Ol)-1-Propyl-4-Hydroxybenzene)-3-Phenylpropylamide  
Isolated stereoisomeric forms of the compound (S)2-N(3-O-(propan 2-ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide and uses in the treatment of pain.
US20110177140 4-AMIDINO BENZYLAMINES FOR COSMETIC AND/OR DERMATOLOGICAL USE  
This invention relates to the use of 4-amidino benzylamine derivatives as cosmetic ingredients and to cosmetic compositions, as well as to non-therapeutic methods for the cosmetic treatment of the...
US20140255963 Degradable Detergents  
Methods and materials relate to degradable detergents. The degradable detergents have degradable linkages that are cleaved when subjected to elevated temperature and/or reduced pressure. The...
US20130200291 Tertiary Amine-Based Switchable Cationic Surfactants and Methods and Systems of Use Thereof  
The present application provides switchable cationic surfactants based on tertiary amines, and methods and systems of use thereof. The tertiary amine structure allows these switchable surfactants...
US20120196938 Beta 2 Adrenergic Receptor Agonists Such As Terbutaline for Use in the Treatment of Nocturnal Hypoglycemia  
The invention is concerned with methods, regimens and dosage forms employing a beta 2 adrenergic receptor agonist such as terbutaline sulphate, for treating nocturnal hypoglycaemia in human...
US20110156011 BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME  
The present invention relates to a blue fluorescence compound which enables to achieve high brightness, a long lifetime and high efficiency; and an organic electroluminescence device thereof.
US20140171415 FUNNY CURRENT (IF) INHIBITORS FOR USE IN A METHOD OF TREATING AND PREVENTING HEART DISEASE IN CANINE  
The present invention relates to an If blocker or a pharmaceutically acceptable salt thereof for the treatment and/or prevention of a canine patient suffering from heart diseases, preferably heart...
US20120004092 Method for Regenerating an Adsorber or Absorber  
A method for regenerating an adsorber or absorber on board a submarine, wherein the adsorber or absorber is present in the interior of the submarine for binding metabolically generated...
US20140319064 Ethylenediamine core, octamethylenephosphonic acid terminated, PAMAM dendrimer and its use as antiscalant  
A preparation method of ethylenediamine core, octamethylenephosphonic acid terminated, PAMAM dendrimer and application thereof is provided, wherein terminal amino groups of ethylenediamine core, 0...
US20140011857 SMALL MOLECULES AS EPIGENETIC MODULATORS OF LYSINE-SPECIFIC DEMETHYLASE 1 AND METHODS OF TREATING DISORDERS  
The invention provides for novel compounds which are inhibitors of lysine-specific demethylase 1 (LSD1). Such compounds may be used to treat disorders, including cancer.
US20140135300 Acetamide Stereoisomer  
The compound of formula (I) is a water-stable, long acting β2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible ...
US20130296607 Acetamide Stereoisomer  
The compound of formula (I) is a water-stable, long acting β2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible ...
US20130052678 URACIL-SPECIFIC FLUORESCENCE DETECTION REACTION AND METHOD FOR EXAMINING DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY  
The invention provides a method of detecting uracil. The method comprises reacting uracil with a compound represented by the formula (I) in the presence of an oxidant and a base to produce a...
US20110021826 CRYSTALLIZATION OF IODIXANOL USING MILLING  
This invention relates to the manufacture of iodixanol(1,3-bis(acetamido)-N,N′-bis[3,5-bis(2,3-dihydrox ypropylaminocarbonyl)-2,4,6-triiodophenyl]-2-hydroxypropane) , more specifically to the p...
US20110067957 Method for lubricating wind turbine gearbox  
A method of lubricating a wind turbine gearbox comprising using a lubricating composition comprising at least one (i.e. one or a mixture of more than one) perfluoropolyether (PFPE) lubricant which...
US20120004404 RADIOLABELLING METHODS  
The present invention relates to the field of [18F] radiofluorination chemistry for the preparation of Positron Emission Tomography (PET) radioligands and [18F] radiofluorinating reagents. The...
US20120216678 ABSORBENT COMPOSITION AND PROCESS FOR REMOVING CO2 AND/OR H2S FROM A GAS COMPRISING CO2 AND/OR H2S  
An absorbent composition for removing CO2 and/or H2S from a gas comprising a polyamine, a monoamine and water, wherein the polyamine comprises a polyamine having 3 to 5 amine functions and has a...
US20110245444 TRANSFORMATION OF BIOMASS  
A method for processing biomass comprising heating an aqueous slurry comprising biomass, water and a phosphate catalyst in a pressure vessel at a temperature of about 150° C. to about 500° C. to p...
US20140194605 SERS Reporter Molecules and Methods  
A SERS tag comprising a core comprising at least two aggregated particles of a SERS enhancing material wherein the contact point between the particles defines a crevice; and a reporter molecule...
US20120156491 SERS Reporter Molecules and Methods  
A SERS tag comprising a core comprising at least two aggregated particles of a SERS enhancing material wherein the contact point between the particles defines a crevice; and a reporter molecule...
US20110021829 SYTNHESIS OF IODIXANOL IN METHANOL  
This invention relates to the synthesis of iodixanol (1,3-bis(acetamido)-N,N′-bis[3,5-bis(2,3-dihydroxypropylam inocarbonyl)-2,4,6-triiodophenyl]-2-hydroxypropane), more specifically to the d...